Preimplantation Genetic Testing in Women of Advanced Maternal Age

Description

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

Conditions

Infertility, Female

Study Overview

Study Details

Study overview

The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.

GEnetic Testing in Elective Single Embryo Transfer in Women of Advanced Maternal Age

Preimplantation Genetic Testing in Women of Advanced Maternal Age

Condition
Infertility, Female
Intervention / Treatment

-

Contacts and Locations

Margate

IVF Florida Reproductive Associates, Margate, Florida, United States, 33063

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
  • * Utilization of Intracytoplasmic Sperm Injection ICSI
  • * Utilization of ejaculated or testicular sperm
  • * Utilization of autologous or donor sperm
  • * All Controlled Ovarian Hyperstimulation (COH) protocols
  • * Patients with anovulatory Polycystic ovarian syndrome (PCOS)
  • * Utilization of donor oocytes
  • * Utilization of gestational carrier
  • * Recurrent Pregnancy Loss (RPL) defined as ≥ 3 consecutive miscarriages
  • * Recurrent Implantation Failure (RIF) defined as ≥ 3 more failed embryo transfers

Ages Eligible for Study

35 Years to 40 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Genomic Prediction Inc.,

Nathan R Treff, PhD, PRINCIPAL_INVESTIGATOR, Genomic Prediction

Study Record Dates

2024-12